DeutschNewstral
Article
Forbes on 2021-04-20 17:08
EU Warns Of 'Possible Link' Between Johnson & Johnson Vaccine And Blood Clots—But Says Benefits Still Outweigh Risks
Related news
- SEU regulator finds possible link between AstraZeneca vaccine and rare blood clots but says benefits outweigh risksscmp.com
- U.K. Reports 30 Cases Of Rare Blood Clots Linked To AstraZeneca Vaccine, Insists Benefits Outweigh Any RisksForbes
EU agency finds ‘possible link’ between J&J shot and rare blood clots, but says benefits outweigh risksAlaska Dispatch News
EU regulator finds link between Johnson & Johnson shot and blood clotsDenver Post- SEuropean drug watchdog backs Johnson & Johnson vaccine despite ‘possible link’ to blood clotsscmp.com
European agency finds AstraZeneca can cause rare blood clots, but benefits outweigh risksCNN
UK: Benefits outweigh risks for AstraZeneca despite 7 deathsMerced Sun-Star
Official says there’s ‘clear link’ between AstraZeneca vaccine, blood clotsNew York Post- EU drug regulator finds ‘possible link’ between AstraZeneca vaccine and rare clots but says benefits still outweigh risksAlaska Dispatch News
British officials confirm 7 deaths from rare blood clots after AstraZeneca shots, but say benefits ‘continue to outweigh any risks’kentucky.com- EU medicines regulator finds possible link between Johnson & Johnson vaccine and blood clotsCNN
EU regulator finds possible link between AstraZeneca vaccine and rare blood clotsreuters.com- EU agency finds ‘possible link’ between J&J vaccine, blood clotsNew York Post
- HEU Drug Regulator Finds Link Between AstraZeneca Vaccine and Blood Clotshamodia.com
- ‘Very rare’ blood clots may have ‘possible link’ to AstraZeneca COVID vaccine, EU regulator findsMerced Sun-Star
EU drug regulator finds link between AstraZeneca vaccine and blood clotsThe Jerusalem Post (JPost.com)
Blood clots should be listed as rare Johnson & Johnson side effect - EMAtimesofmalta.com
EU regulator backs use of Johnson & Johnson COVID-19 vaccine despite finding possible link to blood clotsCBC
7 UK AstraZeneca recipients die of clots; regulator: Benefits outweigh riskstimesofisrael.com